Huntington's Disease Research
Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.
Huntington's Disease Research Products Targets
- Adenosine A2A Receptor (11)
- Caspase (9)
- Ubiquitin-activating Enzyme E1 (3)
- Ubiquitin E2 Conjugating Enzyme (3)
- Ubiquitin E3 Ligase (10)
- Deubiquitinating Enzyme (12)
- Hsp90 (10)
- Hsp70 (4)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- Vesicular Monoamine Transporter (4)
- Sir 2-like Family Deacetylase (9)
- Post-Translational Modification (11)
- NMDA Receptor (87)
- Kainate Receptor (22)
- IP3 Receptor (2)
- ERK (6)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Calpain (7)
- Trk Receptor (13)
- Autophagy (44)
- Antioxidant (19)
- Glutamate Transporter (18)
- Dopamine Transporter (20)
- Cathepsin (9)
- Mitochondrial Permeability Transition Pore (3)
- Proteasome (5)
- Histone Deacetylase (19)
- Histone Acetyltransferase (4)
Products for Huntington's Disease Research - Page 25
- Cat.No. Product Name Information/Activity
-
BCC7369
Co 101244 hydrochloride
193356-17-1
-
BCC6120
Conantokin G
93438-65-4
-
BCC5980
Conantokin-R
202925-60-8
-
BCC5977
Conantokin-T
127476-26-0
-
BCC6581
(R)-CPP
126453-07-4
-
BCC6561
(RS)-CPP
100828-16-8
-
BCC6999
D-CPP-ene
117414-74-1
-
BCC6592
5,7-Dichlorokynurenic acid
131123-76-7
-
BCC7758
5,7-Dichlorokynurenic acid sodium salt
1184986-70-6
-
BCC6619
(±)-1-(1,2-Diphenylethyl)piperidine maleate
207461-99-2
